Vera Therapeutics (VERA) insider buying

Healthcare · Biotechnology · Market cap $1.9B

3 open-market purchases of VERA by Vera Therapeutics's executives and directors since June 2025, worth $6M in total, from SEC Form 4 filings.

The most recent: Patrick G Enright bought $249,985 on December 11, 2025.

The biggest buyer over the period is Patrick G Enright: 3 purchases, $6M.

By year

YearPurchasesValue
20253$6M

Biggest buyers

InsiderBuysValue
Patrick G Enright
3$6M

Every purchase

Newest first. From SEC Form 4 filings. Insider buying across the market.

DateInsiderSharesPriceValueFiling
Dec 11, 2025 Patrick G Enright
 5,882$42.50$249,985 Form 4
Jun 24, 2025 Patrick G Enright
 40,607$22.35$907,566 Form 4
Jun 23, 2025 Patrick G Enright
 209,393$20.87$4M Form 4
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for VERA.
Open VERA in Investingly

Questions

Are Vera Therapeutics insiders buying the stock?

3 open-market purchases of VERA by Vera Therapeutics's executives and directors since June 2025, worth $6M in total, from SEC Form 4 filings. The most recent: Patrick G Enright bought $249,985 on December 11, 2025.

What counts as insider buying here?

Open-market purchases (Form 4 code P) by officers and directors. Option exercises, grants and purchases by 10% owners are left out.

From Vera Therapeutics's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.